Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025
   Core EBITDA Growth(%) 72.22-

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 72.22 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202672.22
Mar2025-

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 72.22
0
Mar2025 0 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹2,623.6 Cr 13.4% 9.1% 233.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

13.4%

9.1%

233.1%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses